Home › Funds › BAKER BROS. ADVISORS LP › INSM

BAKER BROS. ADVISORS LP position in INSM

INSMED INC · Health Care

BAKER BROS. ADVISORS LP reported holding 8,796,111 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$937.8M, representing 4.90% of its reported portfolio and ranking #7 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed INSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)8.80M sh
Reported value held$937.84M
Portfolio Weight4.90%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's INSM position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in INSM in Q3 2023 at 343,000 shares (US$8.7M). The position peaked in Q1 2026 at 7,421,111 shares, worth US$1.21B. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 8,796,111 shares valued at US$937.8M — an increase of 1,375,000 shares quarter over quarter.. Notable position changes include a 943% increase in Q2 2024 (shares rose 8% over the following quarter), a 43% increase in Q2 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 343.00K $8.66M New
Q4 2023 343.00K $10.63M Hold
Q1 2024 343.00K $9.31M Hold
Q2 2024 3.58M $239.59M Add
Q3 2024 4.42M $322.36M Add
Q4 2024 5.01M $345.67M Add
Q1 2025 5.38M $410.49M Add
Q2 2025 7.71M $776.23M Add
Q3 2025 6.70M $965.37M Reduce
Q4 2025 6.59M $1.15B Reduce
Q1 2026 7.42M $1.21B Add
Q2 2026 8.80M $937.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 39 other funds we track also report a position in INSM — the largest reported positions include Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M), D. E. Shaw & Co (US$633.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held INSM?

BAKER BROS. ADVISORS LP has disclosed INSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in INSM?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 8.80M shares of INSM (INSMED INC), valued at $937.84M, representing 4.90% of its reported portfolio and ranking #7.

Has BAKER BROS. ADVISORS LP been buying or selling INSM?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in INSM. The position peaked in Q1 2026 at 7.42M shares.

Which other funds hold INSM?

Other major institutional holders of INSM include Darwin Global Management, Ltd., Orbis Allan Gray Ltd, D. E. Shaw & Co, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.